Zeria Pharmaceutical Co., Ltd.
4559.T
Price:
$2101
Market Cap:
$92.61B
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-01-01
Stock Exchange
JPX
Ticker
4559.T
PE Ratio
[16.50]
ROE
[6.35%]
Current Ratio
[1.31]
Dividend Yield
[2.24%]
Enterprise Value
[109.92B]
Dividend History
The Current Ratio as of December 2025 (TTM) for Zeria Pharmaceutical Co., Ltd. (4559.T) is 1.31
According to Zeria Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.31. This represents a change of 3.51% compared to the average of 1.27 of the last 4 quarters.
Zeria Pharmaceutical Co., Ltd. (4559.T) Historical Current Ratio (quarterly & annually)
How has 4559.T Current Ratio performed in the past?
The mean historical Current Ratio of Zeria Pharmaceutical Co., Ltd. over the last ten years is 0.96. The current 1.31 Current Ratio has changed 13.53% with respect to the historical average. Over the past ten years (40 quarters), 4559.T's Current Ratio was at its highest in in the September 2025 quarter at 1.31. The Current Ratio was at its lowest in in the March 2021 quarter at 0.69.
Average
0.96
Median
0.97
Minimum
0.69
Maximum
1.28
Zeria Pharmaceutical Co., Ltd. (4559.T) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Zeria Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.82%
Maximum Annual Current Ratio = 1.28
Minimum Annual Increase = -60.53%
Minimum Annual Current Ratio = 0.69
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.28 | 20.43% |
| 2024 | 1.06 | 3.74% |
| 2023 | 1.02 | 8.42% |
| 2022 | 0.94 | 35.82% |
| 2021 | 0.69 | -18.60% |
| 2020 | 0.85 | -14.48% |
| 2019 | 1.00 | -8.16% |
| 2018 | 1.09 | 26.52% |
| 2017 | 0.86 | 4.29% |
| 2016 | 0.82 | -60.53% |
Zeria Pharmaceutical Co., Ltd. (4559.T) Average Current Ratio
How has 4559.T Current Ratio performed in the past?
The current Current Ratio of Zeria Pharmaceutical Co., Ltd. (4559.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.12
5-year avg
1.00
10-year avg
0.96
Zeria Pharmaceutical Co., Ltd. (4559.T) Current Ratio vs. Peers
How is 4559.T’s Current Ratio compared to its peers?
Zeria Pharmaceutical Co., Ltd.’s Current Ratio is less than KYORIN Holdings, Inc. (4.70), less than Mochida Pharmaceutical Co., Ltd. (4.73), less than ASKA Pharmaceutical Holdings Co.,Ltd. (2.51), less than Menicon Co., Ltd. (2.82), less than Japan Lifeline Co., Ltd. (3.30), less than Eiken Chemical Co., Ltd. (2.17), less than Kaken Pharmaceutical Co., Ltd. (4.40), less than Nxera Pharma Co., Ltd. (3.14), greater than Qol Holdings Co., Ltd. (0.75), less than Towa Pharmaceutical Co., Ltd. (2.80),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.70 | $87.78B | |
| 4.73 | $123.54B | |
| 2.51 | $57.90B | |
| 2.82 | $117.94B | |
| 3.30 | $108.68B | |
| 2.17 | $81.07B | |
| 4.40 | $154.50B | |
| 3.14 | $77.83B | |
| 0.75 | $82.46B | |
| 2.80 | $179.93B |
Build a custom stock screener for Zeria Pharmaceutical Co., Ltd. (4559.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zeria Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Zeria Pharmaceutical Co., Ltd. (4559.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Zeria Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Zeria Pharmaceutical Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Zeria Pharmaceutical Co., Ltd. (4559.T)?
What is the highest Current Ratio for Zeria Pharmaceutical Co., Ltd. (4559.T)?
What is the 3-year average Current Ratio for Zeria Pharmaceutical Co., Ltd. (4559.T)?
What is the 5-year average Current Ratio for Zeria Pharmaceutical Co., Ltd. (4559.T)?
How does the current Current Ratio for Zeria Pharmaceutical Co., Ltd. (4559.T) compare to its historical average?